We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+4.1%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.02%
AUM
$1.99B
AUM Growth
+$284M
(+17%)
Cap. Flow
+$258M
Cap. Flow
% of AUM
12.95%
Top 10 Holdings %
Top 10 Hldgs %
13.22%
Holding
2,248
New
441
Increased
650
Reduced
654
Closed
492
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SAGE
Sage Therapeutics
SAGE
|
+$11.9M |
| 2 |
Insulet
PODD
|
+$11.1M |
| 3 |
ZEN
ZENDESK INC
ZEN
|
+$10.8M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$10.7M |
| 5 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$10.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$59.2M |
| 2 |
GoDaddy
GDDY
|
+$10.6M |
| 3 |
Palo Alto Networks
PANW
|
+$10.5M |
| 4 |
Citigroup
C
|
+$8.89M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$7.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.96% |
| 2 | Consumer Discretionary | 13.01% |
| 3 | Healthcare | 12.59% |
| 4 | Industrials | 12.57% |
| 5 | Financials | 11.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QHC
1326
DELISTED
Quorum Health Corporation
QHC
| $208K | 0.01% |
41,640
+6,384
| +18% | +$40.9K |
|
|
EFII
1327
DELISTED
Electronics for Imaging
EFII
| $208K | 0.01% |
6,382
-24,639
| -79% | -$784K |
|
1328
Red Robin
RRGB
$149M
| $207K | 0.01% |
+4,435
| New | +$251K |
|
1329
Sea Limited
SE
$68.3B
| $207K | 0.01% |
+13,790
| New | +$177K |
|
|
RDC
1330
DELISTED
Rowan Companies Plc
RDC
| $207K | 0.01% |
12,762
-21,480
| -63% | -$323K |
|
|
MNR
1331
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $207K | 0.01% |
12,552
+990
| +9% | +$15.3K |
|
1332
Allient
ALNT
$1.61B
| $206K | 0.01% |
+6,447
| New | +$193K |
|
|
FSP
1333
Franklin Street Properties
FSP
$48.4M
| $206K | 0.01% |
+24,069
| New | +$191K |
|
1334
Federal Signal
FSS
$8.09B
| $206K | 0.01% |
+8,856
| New | +$206K |
|
1335
Kforce
KFRC
$1.04B
| $206K | 0.01% |
5,993
-1,222
| -17% | -$38.5K |
|
1336
Teradyne
TER
$63.1B
| $206K | 0.01% |
5,400
-1,097
| -17% | -$42.7K |
|
|
VNET
1337
VNET Group
VNET
$2.06B
| $206K | 0.01% |
21,262
-13,324
| -39% | -$94.7K |
|
|
ECOM
1338
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $206K | 0.01% |
14,645
+4,975
| +51% | +$65.3K |
|
|
CTRL
1339
DELISTED
Control4 Corporation
CTRL
| $206K | 0.01% |
8,468
-8,661
| -51% | -$202K |
|
1340
B&G Foods
BGS
$289M
| $205K | 0.01% |
+6,866
| New | +$184K |
|
1341
CarGurus
CARG
$3.34B
| $205K | 0.01% |
+5,890
| New | +$198K |
|
1342
Korea Electric Power
KEP
$15.8B
| $205K | 0.01% |
+14,319
| New | +$231K |
|
1343
Polaris
PII
$4.2B
| $205K | 0.01% |
1,678
-2,929
| -64% | -$343K |
|
1344
Toro Company
TTC
$9.44B
| $205K | 0.01% |
3,398
+1,966
| +137% | +$118K |
|
1345
Verisk Analytics
VRSK
$25.1B
| $205K | 0.01% |
1,905
-3,957
| -68% | -$421K |
|
1346
Vail Resorts
MTN
$5.33B
| $204K | 0.01% |
743
-1,064
| -59% | -$261K |
|
1347
Thermo Fisher Scientific
TMO
$209B
| $204K | 0.01% |
986
-15,944
| -94% | -$3.38M |
|
|
AMED
1348
DELISTED
Amedisys
AMED
| $203K | 0.01% |
2,372
+2,172
| +1,086% | +$159K |
|
1349
Manulife Financial
MFC
$74.4B
| $203K | 0.01% |
11,304
-4,682
| -29% | -$88.2K |
|
1350
Supernus Pharmaceuticals
SUPN
$2.51B
| $203K | 0.01% |
+3,400
| New | +$176K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q2 2018 Portfolio in Review
As of Q2 2018, Cubist Systematic Strategies held 2,248 positions worth $1.99B, up 17% from $1.71B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Cubist Systematic Strategies deployed $258M of net new capital in Q2 2018, opening 441 new positions and adding to 650 existing holdings. Its largest new stake was Sage Therapeutics: 76,110 shares worth $11.9M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $59.2M trimmed.
- Cubist Systematic Strategies's largest Q2 2018 buy was Sage Therapeutics: 76,110 shares worth $11.9M.
- Cubist Systematic Strategies added most to ZENDESK INC in Q2 2018, an estimated $10.8M increase.
- Cubist Systematic Strategies's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $59.2M.
- Cubist Systematic Strategies fully exited TJX Companies in Q2 2018, selling an estimated $6.46M.
- Cubist Systematic Strategies's ten largest holdings make up 13% of its $1.99B portfolio in Q2 2018.
- Cubist Systematic Strategies opened 441 new positions and closed 492 in Q2 2018.
- Cubist Systematic Strategies's portfolio value rose 17% quarter-over-quarter to $1.99B.
Based on Cubist Systematic Strategies's 13F filing for Q2 2018, filed 14 Aug 2018.